Volume | 172,106 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.45 | Mínimo Máximo |
|||||
Minimo del Dia | 2.17 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Lexaria Bioscience Corporation | LEXX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.17 | 2.17 | 2.45 | 2.35 | 2.19 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
514 | 172,106 | US$ 2.27 | US$ 390,353 | - | 0.6488 - 6.85 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:21:32 | 1 | US$ 2.35 | USD |
Información Financiera Lexaria Bioscience Corporation LEXX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
0 | 10.28M | - | 226k | -6.67M | - | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Lexaria Bioscience Corporation LEXX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
06/3/2024 | 05:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
01/3/2024 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 14:47 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
14/2/2024 | 13:20 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
14/2/2024 | 11:00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
30/1/2024 | 12:51 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 13:12 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 12:33 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
18/1/2024 | 13:38 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
12/1/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/1/2024 | 07:30 | GlobeNewswire Inc. | Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary.. |
Histórico de Datos LEXX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.26 | 2.45 | 2.15 | 2.22 | 54,223 | 0.09 | 3.98% |
1 Month | 3.82 | 3.82 | 1.85 | 2.59 | 192,263 | -1.47 | -38.48% |
3 Months | 1.61 | 6.85 | 1.50 | 3.55 | 522,971 | 0.74 | 45.96% |
6 Months | 1.12 | 6.85 | 1.08 | 3.11 | 308,315 | 1.23 | 109.82% |
1 Year | 2.18 | 6.85 | 0.6488 | 2.42 | 221,395 | 0.17 | 7.80% |
3 Years | 5.31 | 12.50 | 0.6488 | 5.24 | 363,892 | -2.96 | -55.74% |
5 Years | 4.05 | 12.50 | 0.6488 | 5.29 | 350,484 | -1.70 | -41.98% |